BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15596054)

  • 1. RNA interference of VCP/p97 increases Mallory body formation.
    Nan L; Wu Y; Bardag-Gorce F; Li J; French BA; Wilson LT; Khanh Nguyen S; French SW
    Exp Mol Pathol; 2005 Feb; 78(1):1-9. PubMed ID: 15596054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p62 is involved in the mechanism of Mallory body formation.
    Nan L; Wu Y; Bardag-Gorce F; Li J; French BA; Fu AN; Francis T; Vu J; French SW
    Exp Mol Pathol; 2004 Dec; 77(3):168-75. PubMed ID: 15507232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mallory body as an aggresome: in vitro studies.
    Riley NE; Li J; Worrall S; Rothnagel JA; Swagell C; van Leeuwen FW; French SW
    Exp Mol Pathol; 2002 Feb; 72(1):17-23. PubMed ID: 11784119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p105/50 NF-kappaB pathway is essential for Mallory body formation.
    Nan L; Wu Y; Bardag-Gorce F; Li J; French BA; Wilson LT; French SW
    Exp Mol Pathol; 2005 Jun; 78(3):198-206. PubMed ID: 15924871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor.
    Nan L; Dedes J; French BA; Bardag-Gorce F; Li J; Wu Y; French SW
    Exp Mol Pathol; 2006 Jun; 80(3):228-40. PubMed ID: 16563375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates.
    Kobayashi T; Manno A; Kakizuka A
    Genes Cells; 2007 Jul; 12(7):889-901. PubMed ID: 17584300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis.
    Wójcik C; Yano M; DeMartino GN
    J Cell Sci; 2004 Jan; 117(Pt 2):281-92. PubMed ID: 14657277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation.
    Bardag-Gorce F; Riley NE; Nan L; Montgomery RO; Li J; French BA; Lue YH; French SW
    Exp Mol Pathol; 2004 Feb; 76(1):9-16. PubMed ID: 14738863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
    Weihl CC; Miller SE; Hanson PI; Pestronk A
    Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the ubiquitin-proteasome pathway in the formation of mallory bodies.
    Bardag-Gorce F; van Leeuwen FW; Nguyen V; French BA; Li J; Riley N; McPhaul LW; Lue YH; French SW
    Exp Mol Pathol; 2002 Oct; 73(2):75-83. PubMed ID: 12231209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
    Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
    Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mallory bodies formed in proteasome-depleted hepatocytes: an immunohistochemical study.
    Bardag-Gorce F; French BA; Lue YH; Nguyen V; Wan YJ; French SW
    Exp Mol Pathol; 2001 Feb; 70(1):7-18. PubMed ID: 11170786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1).
    Bardag-Gorce F; Riley N; Nguyen V; Montgomery RO; French BA; Li J; van Leeuwen FW; Lungo W; McPhaul LW; French SW
    Exp Mol Pathol; 2003 Apr; 74(2):160-7. PubMed ID: 12710947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mallory body forming cells express the preneoplastic hepatocyte phenotype.
    Nan L; Bardag-Gorce F; Wu Y; Li J; French BA; French SW
    Exp Mol Pathol; 2006 Apr; 80(2):109-18. PubMed ID: 16413534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of valosin-containing protein (VCP/p97) in untransformed osteoblast-like cells.
    Behnam K; Murray SS; Brochmann EJ
    J Orthop Res; 2005 May; 23(3):618-24. PubMed ID: 15885483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study.
    Riley NE; Bardag-Gorce F; Montgomery RO; Li J; Lungo W; Lue YH; French SW
    Exp Mol Pathol; 2003 Apr; 74(2):173-9. PubMed ID: 12710949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation.
    Hirano K; Roth J; Zuber C; Ziak M
    Histochem Cell Biol; 2002 Jan; 117(1):41-53. PubMed ID: 11819096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid-induced Mallory body formation in drug-primed mouse liver.
    Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H
    Am J Pathol; 2002 Dec; 161(6):2019-26. PubMed ID: 12466118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretory function in cultured hepatocytes from griseofulvin-treated mice.
    Kawahara H; Marceau N; French SW
    Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.